StockData
USANA Health Sciences Inc logo

USANA Health Sciences Inc (USNA) stock

USNANYSEMedicinal Chemicals & Botanical ProductsFiscal year ends January 3
Financials through Q2 FY2026, quarter ended Jul 4, 2026Last filing: 10-Q on Nov 12, 2026Score 11/3058% below fair value
$13.57+0.03 (+0.22%)

Close on Nov 17, 2026Market cap $250.73MP/E –Yield –

USANA Health Sciences price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

USANA Health Sciences's price to sales ratio was 0.3× on Nov 11, 2026, against 0.4× a year earlier. Over the last 5 years it ranged from 0.3× to 1.6×, with a median of 0.9×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.3×−0.1
2025Dec 31, 20250.4×−0.4
2024Dec 31, 20240.8×−0.3
2023Dec 29, 20231.1×+0.1
2022Dec 30, 20221.0×−0.6
2021Dec 31, 20211.6×+0.1
2020Dec 31, 20201.5×−0.1
2019Dec 31, 20191.6×−0.9
2018Dec 31, 20182.4×+0.7
2017Dec 29, 20171.7×+0.2
2016Dec 30, 20161.5×−0.3
2015Dec 31, 20151.8×+0.1
2014Dec 31, 20141.7×+0.2
2013Dec 31, 20131.5×+0.7
2012Dec 31, 20120.8×−0.0
2011Dec 30, 20110.8×−0.7
2010Dec 31, 20101.5×–

More USANA Health Sciences figures

See a number that looks wrong?